tiprankstipranks
Rapport Therapeutics Inc trading resumes
PremiumThe FlyRapport Therapeutics Inc trading resumes
24d ago
Rapport Therapeutics Inc trading halted, volatility trading pause
Premium
The Fly
Rapport Therapeutics Inc trading halted, volatility trading pause
24d ago
Premium
Company Announcements
Rapport Therapeutics Appoints New CMO Amid Phase 2a Updates
25d ago
Rapport Therapeutics presents data on long episode seizure biomarker
PremiumThe FlyRapport Therapeutics presents data on long episode seizure biomarker
4M ago
Two new option listings and one option delisting on November 21st
Premium
The Fly
Two new option listings and one option delisting on November 21st
4M ago
Rapport Therapeutics to present data at AES Annual Meeting
Premium
The Fly
Rapport Therapeutics to present data at AES Annual Meeting
4M ago
Rapport Therapeutics initiated with a Buy at JonesResearch
PremiumThe FlyRapport Therapeutics initiated with a Buy at JonesResearch
5M ago
Rapport Therapeutics sees cash runway through end of 2026
Premium
The Fly
Rapport Therapeutics sees cash runway through end of 2026
8M ago
Rapport Therapeutics reports Q2 EPS ($1.70), consensus (67c)
Premium
The Fly
Rapport Therapeutics reports Q2 EPS ($1.70), consensus (67c)
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100